Management of NCD in Low- and Middle-Income Countries
William Checkley(Johns Hopkins University), Lijing L. Yan(Duke University), Dorairaj Prabhakaran(Dignity Health), Nikhil Tandon, Adolfo Rubinstein(Instituto de Efectividad Clínica y Sanitaria), Richard D. Smith, Alben Sigamani, Hassen Ghannem(Hôpital Farhat Hached), Vilma Irazola(Instituto de Efectividad Clínica y Sanitaria), Louis Niessen(Johns Hopkins University), Denis Xavier(McMaster University), Naomi Levitt(University of Cape Town), Manuel Ramírez‐Zea(Institute of Nutrition of Central America and Panama), Yangfeng Wu(Peking University), J. Jaime Miranda(Universidad Peruana Cayetano Heredia), Sylvester Kimaiyo(Moi University), Cristina Rabadan‐Diehl(National Institutes of Health)
Cited by 144
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k